|
1
|
Rodeghiero F, Stasi R, Gernsheimer T, et
al: Standardization of terminology, definitions and outcome
criteria in immune thrombocytopenic purpura of adults and children:
report from an international working group. Blood. 113:2386–2393.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gernsheimer T: Chronic idiopathic
thrombocytopenic purpura: mechanisms of pathogenesis. Oncologist.
14:12–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou B, Zhao H, Yang RC and Han ZC:
Multi-dysfunctional pathophysiology in ITP. Crit Rev Oncol Hematol.
54:107–116. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Semple JW: Immune pathophysiology of
autoimmune thrombocytopenic purpura. Blood Rev. 16:9–12. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coopamah MD, Garvey MB, Freedman J and
Semple JW: Cellular immune mechanisms in autoimmune
thrombocytopenic purpura: An update. Transfus Med Rev. 17:69–80.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Panitsas FP, Theodoropoulou M, Kouraklis
A, et al: Adult chronic idiopathic thrombocytopenic purpura (ITP)
is the manifestation of a type-1 polarized immune response. Blood.
103:2645–2647. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang T, Zhao H, Ren H, et al: Type 1 and
type 2 T-cell profiles in idiopathic thrombocytopenic purpura.
Haematologica. 90:914–923. 2005.PubMed/NCBI
|
|
8
|
Zhang J, Ma D, Zhu X, Qu X, Ji C and Hou
M: Elevated profile of Th17, Th1 and Tc1 cells in patients with
immune thrombocytopenic purpura. Haematologica. 94:1326–1329. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
von Boehmer H: Mechanisms of suppression
by suppressor T cells. Nat Immunol. 6:338–344. 2005.PubMed/NCBI
|
|
10
|
Liu B, Zhao H, Poon MC, et al: Abnormality
of CD4+CD25+ regulatory T cells in idiopathic
thrombocytopenic purpura. Eur J Haematol. 78:139–143. 2007.
|
|
11
|
Sakakura M, Wada H, Tawara I, et al:
Reduced Cd4+Cd25+ T cells in patients with
idiopathic thrombocytopenic purpura. Thromb Res. 120:187–193.
2007.
|
|
12
|
Yu J, Heck S, Patel V, et al: Defective
circulating CD25 regulatory T cells in patients with chronic immune
thrombocytopenic purpura. Blood. 112:1325–1328. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kronenberg M and Gapin L: The
unconventional lifestyle of NKT cells. Nat Rev Immunol. 2:557–568.
2002.PubMed/NCBI
|
|
14
|
Wilson SB and Delovitch TL: Janus-like
role of regulatory iNKT cells in autoimmune disease and tumor
immunity. Nat Rev Immunol. 3:211–222. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Johansson U, Macey MG, Kenny D, Provan D
and Newland AC: Alpha-galactosylceramide-driven expansion of human
natural killer T cells is inhibited by prednisolone treatment. Br J
Haematol. 125:400–404. 2004. View Article : Google Scholar
|
|
16
|
La Cava A, Van Kaer L and Fu DS:
CD4+CD25+ Tregs and NKT cells: regulators
regulating regulators. Trends Immunol. 27:322–327. 2006.
|
|
17
|
Zhang L, Li H, Zhao H, Ji L and Yang R:
Hepatitis C virus-related adult chronic idiopathic thrombocytopenic
purpura: experience from a single Chinese center. Eur J Haematol.
70:196–197. 2003. View Article : Google Scholar
|
|
18
|
Ziegler SF: FOXP3: of mice and men. Annu
Rev Immunol. 24:209–226. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu W, Putnam AL, Xu-Yu Z, et al: CD127
expression inversely correlates with FoxP3 and suppressive function
of human CD4+ T reg cells. J Exp Med. 203:1701–1711.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Johansson U, Macey MG, Kenny D, Provan AB
and Newland AC: The role of natural killer T (NKT) cells in immune
thrombocytopenia: is strong in vitro NKT cell activity related to
the development of remission? Br J Haematol. 129:564–565. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ho LP, Urban BC, Jones L, Ogg GS and
McMichael AJ: CD4−CD8αα subset of CD1d-restricted NKT
cells controls T cell expansion. J Immunol. 172:7350–7358.
2004.
|
|
22
|
Cao J, Chen C, Li L, et al: Effects of
high-dose dexamethasone on regulating interleukin-22 production and
correcting Th1 and Th22 polarization in immune thrombocytopenia. J
Clin Immunol. 32:523–529. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wolk K, Witte E, Witte K, Warszawska K and
Sabat R: Biology of interleukin-22. Semin Immunopathol. 32:17–31.
2010. View Article : Google Scholar
|
|
24
|
Azuma T, Takahashi T, Kunisato A, Kitamura
T and Hirai H: Human CD4+ CD25+ regulatory T
cells suppress NKT cell functions. Cancer Res. 63:4516–4520.
2003.PubMed/NCBI
|
|
25
|
Jiang S, Game DS, Davies D, Lombardi G and
Lechler RI: Activated CD1d-restricted natural killer T cells
secrete IL-2: innate help for CD4+CD25+
regulatory T cells? Eur J Immunol. 35:1193–1200. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Provan D, Stasi R, Newland AC, et al:
International consensus report on the investigation and management
of primary immune thrombocytopenia. Blood. 115:168–186. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zehnder JL, Semple JW, Imbach P, Neufeld
EJ, Buchanan GR and Cines DB: Future research in ITP: an ICIS
consensus. Ann Hematol. 89(Suppl 1): S19–S23. 2010. View Article : Google Scholar
|
